Phibro Animal Health (PAHC) | Financial Analysis & Statements
Phibro Animal Health Corporation Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
373.9M
Gross Profit
132.7M
35.48%
Operating Income
50.3M
13.46%
Net Income
27.5M
7.34%
EPS (Diluted)
$0.67
Balance Sheet Metrics
Total Assets
1.4B
Total Liabilities
1.1B
Shareholders Equity
285.7M
Debt to Equity
3.76
Cash Flow Metrics
Operating Cash Flow
239.0K
Free Cash Flow
8.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Phibro Animal Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.0B | 977.9M | 942.3M | 833.4M |
| Cost of Goods Sold | 896.3M | 704.6M | 679.7M | 656.9M | 562.0M |
| Gross Profit | 399.9M | 313.1M | 298.2M | 285.4M | 271.4M |
| Gross Margin % | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 289.5M | 259.8M | 226.4M | 206.4M | 196.5M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 289.5M | 259.8M | 226.4M | 206.4M | 196.5M |
| Operating Income | 110.5M | 53.3M | 71.8M | 79.0M | 74.9M |
| Operating Margin % | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% |
| Non-Operating Items | |||||
| Interest Income | 2.6M | 4.5M | 3.4M | 816.0K | 838.0K |
| Interest Expense | 33.2M | 22.0M | 17.9M | 12.1M | 11.9M |
| Other Non-Operating Income | -7.9M | -23.9M | -2.5M | 5.2M | 4.5M |
| Pre-tax Income | 68.0M | 10.9M | 54.1M | 72.3M | 66.5M |
| Income Tax | 19.7M | 8.5M | 21.5M | 23.2M | 12.1M |
| Effective Tax Rate % | 29.0% | 77.9% | 39.7% | 32.0% | 18.2% |
| Net Income | 48.3M | 2.4M | 32.6M | 49.2M | 54.4M |
| Net Margin % | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% |
| Key Metrics | |||||
| EBITDA | 154.7M | 92.9M | 108.5M | 111.9M | 105.7M |
| EPS (Basic) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| EPS (Diluted) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| Basic Shares Outstanding | 40500000 | 40504000 | 40504000 | 40500000 | 40500000 |
| Diluted Shares Outstanding | 40500000 | 40504000 | 40504000 | 40500000 | 40500000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Phibro Animal Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 68.0M | 70.6M | 41.3M | 74.2M | 50.2M |
| Short-term Investments | 9.0M | 44.0M | 40.0M | 17.0M | 43.0M |
| Accounts Receivable | 228.0M | 169.5M | 163.5M | 166.5M | 146.9M |
| Inventory | 444.4M | 265.9M | 277.6M | 259.2M | 216.3M |
| Other Current Assets | 61.2M | 51.0M | 63.4M | 49.3M | 42.5M |
| Total Current Assets | 810.6M | 601.0M | 585.7M | 566.2M | 498.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 41.3M | 37.6M | 35.8M | 37.7M | 33.0M |
| Goodwill | 155.8M | 154.1M | 161.5M | 170.3M | 167.6M |
| Intangible Assets | 36.5M | 45.0M | 55.0M | 63.9M | 62.3M |
| Long-term Investments | 89.0K | 0 | 10.2M | 13.0M | 2.7M |
| Other Non-Current Assets | 45.8M | 27.6M | 18.2M | 16.0M | 20.1M |
| Total Non-Current Assets | 550.3M | 381.2M | 385.7M | 365.5M | 342.4M |
| Total Assets | 1.4B | 982.2M | 971.4M | 931.7M | 841.3M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 138.2M | 85.6M | 73.9M | 95.6M | 68.4M |
| Short-term Debt | 25.4M | 37.3M | 28.3M | 21.1M | 16.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 31.2M | 17.5M | 18.9M | 18.9M | 20.8M |
| Total Current Liabilities | 293.5M | 204.1M | 176.0M | 190.8M | 164.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 736.2M | 488.2M | 481.6M | 449.4M | 410.7M |
| Deferred Tax Liabilities | 19.5M | 14.2M | 12.1M | 9.3M | 6.6M |
| Other Non-Current Liabilities | 11.4M | 6.8M | 6.1M | 5.9M | 7.6M |
| Total Non-Current Liabilities | 781.7M | 521.4M | 512.9M | 478.4M | 438.7M |
| Total Liabilities | 1.1B | 725.5M | 688.9M | 669.3M | 602.8M |
| Equity | |||||
| Common Stock | 4.0K | 4.0K | 4.0K | 4.0K | 4.0K |
| Retained Earnings | 272.7M | 243.9M | 260.9M | 247.7M | 218.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 285.7M | 256.6M | 282.5M | 262.4M | 238.5M |
| Key Metrics | |||||
| Total Debt | 761.6M | 525.5M | 510.0M | 470.5M | 426.7M |
| Working Capital | 517.1M | 396.8M | 409.7M | 375.4M | 334.8M |
Balance Sheet Composition
Phibro Animal Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 48.3M | 2.4M | 32.6M | 49.2M | 54.4M |
| Depreciation & Amortization | 45.6M | 36.2M | 34.0M | 32.7M | 31.9M |
| Stock-Based Compensation | 717.0K | 475.0K | 0 | 0 | 1.1M |
| Working Capital Changes | -68.7M | 20.9M | -35.4M | -47.8M | -31.1M |
| Operating Cash Flow | 27.0M | 51.6M | 29.5M | 34.5M | 56.8M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -286.5M | -3.3M | 0 | -13.5M | 0 |
| Investment Purchases | -14.0M | -65.5M | -40.0M | -64.1M | -74.0M |
| Investment Sales | 49.0M | 61.5M | 17.0M | 91.5M | 86.0M |
| Investing Cash Flow | -250.4M | -7.0M | -22.2M | 14.5M | 10.7M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -19.4M | -19.4M | -19.4M | -19.4M | -19.4M |
| Debt Issuance | 1.2B | 276.0M | 326.0M | 297.0M | 617.5M |
| Debt Repayment | -946.0M | -263.3M | -283.3M | -256.4M | -612.1M |
| Financing Cash Flow | 207.1M | -6.8M | 27.0M | 66.3M | -91.0M |
| Free Cash Flow | 41.8M | 46.4M | -38.5M | -5.4M | 19.0M |
| Net Change in Cash | -16.2M | 37.9M | 34.2M | 115.3M | -23.4M |
Cash Flow Trend
Phibro Animal Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.20
Forward P/E
16.14
Price to Book
6.67
Price to Sales
1.51
PEG Ratio
0.03
Profitability Ratios
Profit Margin
6.29%
Operating Margin
14.71%
Return on Equity
31.80%
Return on Assets
8.34%
Financial Health
Current Ratio
3.05
Debt to Equity
233.04
Beta
0.69
Per Share Data
EPS (TTM)
$2.26
Book Value per Share
$8.20
Revenue per Share
$36.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PAHC | 2.2B | 24.20 | 6.67 | 31.80% | 6.29% | 233.04 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Alkermes plc | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Lantheus Holdings | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






